Form 4: Elanco Animal Health Executive Receives Stock Options and Restricted Stock Units
SEC Form 4
Timothy J. Bettington, an Executive Vice President at Elanco Animal Health, was granted stock options and restricted stock units on March 3, 2025, according to a Form 4 filing.
Summary
- On March 3, 2025, Timothy J. Bettington, an Executive Vice President at Elanco Animal Health, received 30,947 restricted stock units.
- These restricted stock units vest in three equal installments on March 3, 2026, March 3, 2027, and March 3, 2028.
- Bettington also received stock options for 64,936 shares with an exercise price of $11.31.
- These stock options also vest in three equal installments on March 3, 2026, March 3, 2027, and March 3, 2028.
- Following these transactions, Bettington directly owns 133,820 shares of Elanco Animal Health stock and 64,936 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices. The grants align executive interests with shareholders, which is generally viewed favorably.
Positives
- The grant of restricted stock units and stock options aligns Mr. Bettington's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Industry Context
Stock option and RSU grants are a common practice in the animal health industry to incentivize and retain key executives.
Comparison to Industry Standards
- Comparing Elanco's executive compensation structure to peers like Zoetis and IDEXX Laboratories would provide a better understanding of whether the size and vesting schedules of these grants are in line with industry norms.
- Analyzing similar grants at these companies can reveal if Elanco's approach is more or less generous in incentivizing its executives.
Stakeholder Impact
- Shareholders may view the grants positively as they incentivize management to improve company performance.
- Employees may see the grants as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the grant of restricted stock units and stock options. |
| 03/03/2026 | First vesting date for one-third of the restricted stock units and stock options. |
| 03/03/2027 | Second vesting date for one-third of the restricted stock units and stock options. |
| 03/03/2028 | Final vesting date for the remaining restricted stock units and stock options. |
| 03/03/2035 | Expiration date of the stock options. |
| 03/05/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.